[H]C12COC(C)OC1([H])C(O)C(O)C(OC1c3cc4c(cc3C(c3cc(OC)c(O)c(OC)c3)C3([H])C(=O)OCC13[H])OCO4)O2
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?